|
CSNK2A1P expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.63430000041676E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.598400E-04 |
| Normal-vs-Stage2 |
4.151500E-02 |
| Normal-vs-Stage3 |
3.04589999888805E-08 |
| Normal-vs-Stage4 |
1.401320E-04 |
| Stage1-vs-Stage2 |
9.290400E-01 |
| Stage1-vs-Stage3 |
7.769100E-04 |
| Stage1-vs-Stage4 |
6.268200E-02 |
| Stage2-vs-Stage3 |
4.411600E-02 |
| Stage2-vs-Stage4 |
2.000400E-01 |
| Stage3-vs-Stage4 |
5.729800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49080000003232E-06 |
| Normal-vs-AfricanAmerican |
3.82840000001661E-06 |
| Normal-vs-Asian |
2.048200E-01 |
| Caucasian-vs-AfricanAmerican |
5.873900E-02 |
| Caucasian-vs-Asian |
7.705600E-01 |
| AfricanAmerican-vs-Asian |
2.893800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12409999997176E-06 |
| Normal-vs-Female |
4.07949999999824E-05 |
| Male-vs-Female |
6.914800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.017700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.246700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.76030000026617E-07 |
| Normal-vs-Age(81-100Yrs) |
2.297900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.005000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.333600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.841400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.673170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.279650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.924000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.594000E-01 |
| Normal-vs-Grade 2 |
3.171200E-04 |
| Normal-vs-Grade 3 |
1.2176999999447E-06 |
| Normal-vs-Grade 4 |
1.98319999999974E-06 |
| Grade 1-vs-Grade 2 |
3.996400E-01 |
| Grade 1-vs-Grade 3 |
1.998170E-01 |
| Grade 1-vs-Grade 4 |
6.740200E-02 |
| Grade 2-vs-Grade 3 |
1.212150E-01 |
| Grade 2-vs-Grade 4 |
8.016100E-03 |
| Grade 3-vs-Grade 4 |
1.608420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.358280E-03 |
| Normal-vs-ccB subtype |
5.015200E-04 |
| ccA subtype-vs-ccB subtype |
3.903400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.982000E-04 |
| Normal-vs-N1 |
3.525200E-01 |
| N0-vs-N1 |
9.717000E-01 |
|
|
